Published in AIDS Weekly, November 3rd, 2003
The placement was led by Scottish Equity Partners (U.K.). Other new investors participating in the financing included ABN AMRO Capital (NL), Avalon Ventures (U.S.), Credit Lyonnais Private Equity (FR) and Sitka Health Fund VCT (U.K.).
All of the company's major existing shareholders also made further investments including; The Merlin Biosciences Fund LP (U.K.), West Deutsche Landesbank Girozentrale (Germany), GeneChem Management of Montreal (Canada), Temasek Holdings (Singapore), Lloyds Development Capital (U.K.) and Technomark Medical Ventures...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.